Samriddhi Shukla
Samriddhi Shukla
Scientist II, Frederick National Laboratory for Cancer Research
No verified email
Cited by
Cited by
Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets
S Khan, S Shukla, S Sinha, SM Meeran
Cytokine & growth factor reviews 24 (6), 503-513, 2013
Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention
S Shukla, SM Meeran, SK Katiyar
Cancer letters 355 (1), 9-17, 2014
Epigenetics of cancer stem cells: Pathways and therapeutics
S Shukla, SM Meeran
Biochimica et Biophysica Acta (BBA)-General Subjects 1840 (12), 3494-3502, 2014
Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications
SM Meeran, SN Patel, Y Li, S Shukla, TO Tollefsbol
PloS one 7 (5), e37748, 2012
Synthesis of β-Carboline-Based N-Heterocyclic Carbenes and Their Antiproliferative and Antimetastatic Activities against Human Breast Cancer Cells
SU Dighe, S Khan, I Soni, P Jain, S Shukla, R Yadav, P Sen, SM Meeran, ...
Journal of Medicinal Chemistry 58 (8), 3485-3499, 2015
Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis
S Shukla, S Sinha, S Khan, S Kumar, K Singh, K Mitra, R Maurya, ...
Scientific reports 6 (1), 1-17, 2016
Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis
S Sinha, S Khan, S Shukla, AD Lakra, S Kumar, G Das, R Maurya, ...
The international journal of biochemistry & cell biology 77, 41-56, 2016
Improved tumor control through t-cell infiltration modulated by ultra-high dose rate proton FLASH using a clinical pencil beam scanning proton system
N Rama, T Saha, S Shukla, C Goda, D Milewski, AE Mascia, RE Vatner, ...
International Journal of Radiation Oncology, Biology, Physics 105 (1), S164-S165, 2019
Cucurbitacin B alters the expression of tumor-related genes by epigenetic modifications in NSCLC and inhibits NNK-induced lung tumorigenesis
S Shukla, S Khan, S Kumar, S Sinha, M Farhan, HK Bora, R Maurya, ...
Cancer prevention research 8 (6), 552-562, 2015
Centchroman suppresses breast cancer metastasis by reversing epithelial–mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling
S Khan, S Shukla, S Sinha, AD Lakra, HK Bora, SM Meeran
The International Journal of Biochemistry & Cell Biology 58, 1-16, 2015
Epigenetics of breast cancer: Clinical status of epi-drugs and phytochemicals
S Shukla, D Penta, P Mondal, SM Meeran
Breast cancer metastasis and drug resistance: challenges and progress, 293-310, 2019
Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells
S Sinha, S Shukla, S Khan, TO Tollefsbol, SM Meeran
Molecular and cellular endocrinology 406, 102-114, 2015
The FOXM1 Inhibitor RCM-1 Decreases Carcinogenesis and Nuclear β-CateninSmall-Molecule Inhibitor of FOXM1 Inhibits Carcinogenesis
S Shukla, D Milewski, A Pradhan, N Rama, K Rice, T Le, MJ Flick, S Vaz, ...
Molecular cancer therapeutics 18 (7), 1217-1229, 2019
Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach
S Krishna, S Shukla, AD Lakra, SM Meeran, MI Siddiqi
Journal of Molecular Graphics and Modelling 75, 174-188, 2017
FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation
M Black, P Arumugam, S Shukla, A Pradhan, V Ustiyan, D Milewski, ...
Molecular Biology of the Cell 31 (13), 1411-1424, 2020
Epigenetic targets in cancer and aging: dietary and therapeutic interventions
S Khan, S Shukla, S Sinha, SM Meeran
Expert opinion on therapeutic targets 20 (6), 689-703, 2016
Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
S Khan, S Shukla, M Farhan, S Sinha, AD Lakra, D Penta, A Kannan, ...
Life Sciences 256, 117976, 2020
Telomeric repeat containing RNA (TERRA): aging and cancer
S Sinha, S Shukla, S Khan, M Farhan, MA Kamal, S Musthapa Meeran
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015
Genetics and epigenetics of lung cancer: mechanisms and future perspectives
S Shukla, S Khan, T O Tollefsbol, S M Meeran
Current Cancer Therapy Reviews 9 (2), 97-110, 2013
FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma
D Milewski, S Shukla, BE Gryder, A Pradhan, J Donovan, P Sudha, ...
Oncogene 40 (12), 2182-2199, 2021
The system can't perform the operation now. Try again later.
Articles 1–20